Adrian Rawcliffe
CIK 1555851 · Chief Executive Officer · last filed 2025-12-10
Adrian Rawcliffe is a Chief Executive Officer who has filed 53 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for WVE, was dated Dec 10, 2025. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.17M
3
53
-$2.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WVE | Director | 54,700 | $5.89 | $322.2K | -$739.4K | 12 | 2025-12-10 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Chief Executive Officer | 44,327 | $0.06 | $2.6K | -$518.7K | 30 | 2025-02-20 |
| ASND | CEO and CFO | 3,318 | $254.44 | $844.2K | -$1.04M | 7 | 2019-09-03 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-10 | WVE | Mixed | — | -$379.3K | EDGAR |
| 2025-12-08 | WVE | Notice (144) | −42,000 | -$314.6K | EDGAR |
| 2025-11-14 | WVE | Sell (S) | −16,115 | -$109.4K | EDGAR |
| 2025-11-13 | WVE | Notice (144) | −16,115 | -$112.1K | EDGAR |
| 2025-08-13 | WVE | Grant (A) | +12,700 | $0 | EDGAR |
| 2025-02-20 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-17 | — | Notice (144) | −30,601 | -$17.8K | EDGAR |
| 2025-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −30,601 | -$17.8K | EDGAR |
| 2025-01-15 | — | Notice (144) | −30,473 | -$17.9K | EDGAR |
| 2025-01-15 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −59,569 | -$34.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.